Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Context Therapeutics Inc. (CNTX) had Return on Equity of -13.25% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-9.69M |
|
-- |
|
-- |
|
$10.61M |
|
$-10.61M |
|
$0.92M |
|
$-9.69M |
|
$-9.69M |
|
$-9.69M |
|
$-9.69M |
|
$-9.69M |
|
$-9.69M |
|
$-10.61M |
|
$-10.61M |
|
95.19M |
|
95.19M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$79.06M |
|
$0.03M |
|
$0.17M |
|
$79.23M |
|
$6.04M |
|
-- |
|
$0.02M |
|
$6.06M |
|
$73.17M |
|
$73.17M |
|
$73.17M |
|
91.88M |
|
| Cash Flow Statement Financials | |
$-17.44M |
|
$-0.03M |
|
$-0.02M |
|
$94.43M |
|
$76.94M |
|
$-17.49M |
|
$1.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-13.25% |
-13.25% |
|
-12.23% |
|
-13.25% |
|
$0.80 |
|
$-0.18 |
|
$-0.18 |
|